Skip to main content
Premium Trial:

Request an Annual Quote

Douglas Edgeton, Alastair James Riddell, Peter Mountford, Alan Greene, Paul Pescatello, Stephen Nocera, Thomas Wootton, Kelly Murphy, Marlon Mathews, Kim Phillips

Edgeton Selected as New President of Piedmont Triad Research Park
Douglas Edgeton, executive vice president and chief operating officer of Wake Forest University Health Sciences, has been appointed president of Piedmont Triad Research Park in Winston-Salem, NC. He succeeds Richard Dean, who retired from the position after five years.
Edgeton’s appointment was approved by PTRP’s board, with concurrence by WFU President Nathan Hatch and the WFU Health Sciences board.
Edgeton previously served as WFU’s senior vice president for health affairs, finance, and administration. He earned MBA and MPH degrees from the University of Alabama in Birmingham, and a BSc from the University of Tuscaloosa [Ala.].

Stem Cell Sciences Names New CEO as Founder Takes CTO Position
Alastair James Riddell has been appointed CEO of Stem Cell Sciences, a stem-cell commercialization company in Edinburgh, Scotland. Riddell succeeds the company’s founder,
Peter Mountford, who has moved to the position of chief technology officer, based in Melbourne, Australia, while retaining his executive directorship.
Riddell previously served as non-executive chairman of Surface Therapeutics, overseeing the company's acquisition by Serentis in September. Before that, he served as CEO of Paradigm Therapeutics, where he and senior managers completed major corporate licensing agreements with Johnson & Johnson and Takeda before leading talks for Takeda's acquisition of the company in March.
From 1998 to 2005, Riddell was CEO of Pharmagene, taking the company through several rounds of venture capital financing and an eventual initial public offering on the London Stock Exchange. Earlier, Riddell held senior management positions at Caremark, Amersham International, Centocor, Celltech, Xoma Europe, and Lederle — after starting his medical career in the Royal Army Medical Corps and the Royal Berkshire Hospital.

Connecticut Innovations Names Two New Officers, New Member to Its Board
Connecticut Innovations, the state’s quasi-public authority responsible for technology investing and innovation development, has appointed two new officers and a new member to its board of directors:
Alan Greene, chief executive officer of AKG Partners, has been named vice chairman of the board. An investor and advisor to high-tech companies, Greene is a Darien, Conn., resident who serves on the board’s audit, compliance and governance committee and previously held positions with Price Waterhouse.
Paul Pescatello, president and CEO of the life sciences trade group Connecticut United for Research Excellence, has served on CI’s board of directors since 1999, the last two years as its secretary, and also chairs CI’s audit committee. As special counsel to Gov. John Rowland in the late 1990s, Pescatello drafted and lobbied for technology company tax and economic development cluster legislation, in collaboration with CURE. He is a member of the Connecticut Department of Public Health’s umbilical cord blood bank committee and the statewide biobank feasibility study committee.
Stephen Nocera, administrative assistant to Torrington, Conn., Mayor Ryan Bingham, has been named the newest member of CI’s board. Nocera, who has held his current position for two years, is a resident of the city who was named to the board by State Rep. Larry Cafero, Republican of Norwalk, Conn.

Two Lawyers Help Firm Expand its IP, Life Sciences/Biotechnology Practices

The law firm Miller Canfield has expanded the intellectual property and life science/biotechnology practices of its Kalamazoo, Mich., office through the hiring of two new lawyers:
Thomas Wootton has been named senior counsel. A former senior patent counsel at Pfizer in Kalamazoo, Wootton specializes in patent preparation and prosecution, and the preparation of patent and technology licensing agreements. A resident of Richland, Mich., Wootton received his JD from Hastings College of Law, University of California, and his BSc from the University of California at Davis, where he concentrated on chemistry, biochemistry and completed graduate work in agricultural chemistry.
Kelly T. Murphy has been named an associate, specializing in patent, licensing and agreement matters. Previously, he served as a technology development associate with the National Institute of Allergy and Infectious Disease in Bethesda, Md. Earlier he was a research associate at Human Genome Sciences in Rockville, Md., and an associate scientist at Invitrogen’s Rockville facility. A resident of Kalamazoo, Murphy received his JD from the Columbus School of Law at The Catholic University of America, and holds an MSc from Western Michigan University with a concentration in molecular biology. He earned a BSc from Western Michigan University where he majored in biological sciences with a minor in chemistry.
Miller Canfield was established in Detroit in 1852 and employs more than 800 in offices in Michigan, Illinois, Massachusetts, Florida, New York, Canada, and Poland.

UC Irvine Postdoc Wins $20,000 Innovation Award From OCTANe Foundation
Marlon Mathews, a postdoctoral scholar in the Department of Neurological Surgery and Beckman Laser Institute and Medical Clinic at the University of California, Irvine, has been recognized as the inaugural Innovation Award winner of the Orange County Technology Action Network’s Foundation for Innovation. OFI’s award recognizes individuals who “have developed an innovative idea, design, patent, product, or discovery that serves as a strong example of the region’s strength in biomedical and information technologies,” according to OCTANe.
Mathews will receive a $20,000 prize, a year’s membership to OCTANe, and business coaching and mentoring through the organization’s LaunchPad program. Mathews’ award was announced at OCTANe’s 2007 Medical Device Conference on November 15 at the Westin South Coast Plaza.

Lincolnville, NC, Economic Agency Taps Outgoing Huntersville, NC, Mayor
Kim Phillips, outgoing mayor of Huntersville, NC, will join the Lincoln [NC] Economic Development Association as business development manager. She will be responsible for marketing and prospect development as well as corporate communications and public relations for LEDA.
Phillips is completing three terms as mayor of Huntersville and earlier served three terms as commissioner. She has been involved with numerous organizations in the Charlotte-Mecklenburg region, including the Lake Norman Region Economic Development Commission; the Capital Budget Advisory Committee; the Planning Commission; the Metropolitan Transit Commission, where she served as vice-chair; the Centralina Council of Government, the Metropolitan Planning Organization; and the Trust for Public Land.
Phillips has a BA in communications from Purdue University and a graduate degree in marketing and finance from the University of Cincinnati, and was formerly employed in sales and marketing for Omni Hotels. She has been involved in commercial, office and industrial recruitment and development in Huntersville. Kim and her husband, Bruce, have three children and live in Denver, NC.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.